caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1659389625

Nurcan IlksoyM.D.

Internal MedicineAtlanta, GAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
106
Unique beneficiaries
—
Total services
232
Distinct HCPCS
4
Medicare payment
$20K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,751 Internal Medicine providers in GA — below median (cohort median 670).
REFERRAL NETWORK

Where Nurcan Ilksoy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Francois Rollin
Internal Medicine · Zuni, NM
1826
BRACEY, JENNIFER1724
Jada Bussey-Jones
Internal Medicine · Atlanta, GA
1635
Kimberly Manning
Internal Medicine · Atlanta, GA
1632
Matthew Zygmont
Diagnostic Radiology · Atlanta, GA
1358
Joel Felner
Internal Medicine · Atlanta, GA
1246
Lisa-Ann Wuermser
Physical Medicine and Rehabilitation · Dallas, TX
1219
LUNDBERG, KRISTINA1127
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
169
Beneficiaries
—
Total drug cost
$18K
Distinct drugs
9
Brand share
8.9%
Top prescribed drugs
Atorvastatin Calcium33 claims
Carvedilol23 claims
Amlodipine Besylate23 claims
Losartan Potassium19 claims
Esomeprazole Magnesium17 claims
QUALITY · MIPS · 2024
Final MIPS score
93.2
Quality
73.7
Cost
75.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.77%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.